| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | TEICHOS LABORATORIES, LLC | 1210 Waterway Blvd Ste 200 | Indianapolis | IN | 46202-2167 | MARION | USA | R43IP001167 | A Totally Synthetic Immunostimulator that Targets Toll-like Receptor 2 and NOD2: Toward Improved Influenza Vaccines | 02 | 1 | CDC | 9/23/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $259,613 ) |
| | 2022 | 2022 | TEICHOS LABORATORIES, LLC | 1220 WATERWAY BLVD | INDIANAPOLIS | IN | 46202-2157 | MARION | USA | R43HL164275 | Immunotherapy for Factor VIII Inhibition in Hemophilia A | 000 | 1 | NIH | 6/10/2022 | $259,613 |
| | 2022 | 2021 | TEICHOS LABORATORIES, LLC | 1220 Waterway Blvd | Indianapolis | IN | 46202-2157 | MARION | USA | R43IP001167 | A Totally Synthetic Immunostimulator that Targets Toll-like Receptor 2 and NOD2: Toward Improved Influenza Vaccines | 01 | 1 | CDC | 9/27/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $243,000 ) |
| | 2021 | 2021 | Teichos Laboratories, LLC | 1281 Win Hentschel Blvd | West Lafayette | IN | 47906-4182 | TIPPECANOE | USA | R43IP001167 | A Totally Synthetic Immunostimulator that Targets Toll-like Receptor 2 and NOD2: Toward Improved Influenza Vaccines | 00 | 1 | CDC | 9/10/2021 | $243,000 |
|
|
